In vitro antibody production (IVAP) in the follow-up of pediatric human immunodeficiency virus type 1-infected patients

Pediatr AIDS HIV Infect. 1997 Apr;8(2):127-9.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibody Specificity / immunology
  • CD4 Lymphocyte Count
  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • HIV Antibodies / metabolism*
  • HIV Core Protein p24 / immunology
  • HIV Envelope Protein gp120 / immunology
  • HIV Envelope Protein gp160 / immunology
  • HIV Envelope Protein gp41 / immunology
  • HIV Infections / immunology*
  • HIV-1 / immunology*
  • Humans
  • Immunoglobulin G / blood
  • In Vitro Techniques
  • Infant
  • Infant, Newborn
  • Male
  • Monocytes / immunology
  • Prognosis

Substances

  • HIV Antibodies
  • HIV Core Protein p24
  • HIV Envelope Protein gp120
  • HIV Envelope Protein gp160
  • HIV Envelope Protein gp41
  • Immunoglobulin G